A detailed history of Fine Mark National Bank & Trust transactions in Novartis Ag stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 14,805 shares of NVS stock, worth $1.44 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,805
Previous 14,772 0.22%
Holding current value
$1.44 Million
Previous $1.57 Million 8.27%
% of portfolio
0.06%
Previous 0.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$106.13 - $120.89 $3,502 - $3,989
33 Added 0.22%
14,805 $1.7 Million
Q2 2024

Aug 02, 2024

SELL
$92.57 - $107.37 $127,376 - $147,741
-1,376 Reduced 8.52%
14,772 $1.57 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $152,050 - $173,118
1,596 Added 10.97%
16,148 $1.56 Million
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $55,085 - $60,619
-597 Reduced 3.94%
14,552 $1.47 Million
Q3 2023

Nov 15, 2023

SELL
$94.73 - $105.13 $67,258 - $74,642
-710 Reduced 4.48%
15,149 $1.54 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $6,476 - $7,343
-70 Reduced 0.44%
15,859 $1.6 Million
Q1 2023

May 08, 2023

SELL
$80.03 - $92.81 $217,921 - $252,721
-2,723 Reduced 14.6%
15,929 $1.47 Million
Q4 2022

Feb 09, 2023

SELL
$75.55 - $92.52 $45,707 - $55,974
-605 Reduced 3.14%
18,652 $1.69 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $49,093 - $57,417
-658 Reduced 3.3%
19,257 $1.46 Million
Q2 2022

Aug 09, 2022

SELL
$80.52 - $93.75 $100,569 - $117,093
-1,249 Reduced 5.9%
19,915 $1.68 Million
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $114,957 - $130,039
-1,435 Reduced 6.35%
21,164 $1.86 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $137,721 - $152,288
-1,728 Reduced 7.1%
22,599 $1.98 Million
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $208,293 - $242,321
-2,547 Reduced 9.48%
24,327 $1.99 Million
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $508,456 - $561,604
-5,965 Reduced 18.16%
26,874 $2.45 Million
Q1 2021

May 12, 2021

SELL
$83.5 - $98.47 $1.11 Million - $1.31 Million
-13,295 Reduced 28.82%
32,839 $2.81 Million
Q4 2020

Feb 10, 2021

SELL
$78.07 - $94.43 $7.82 Million - $9.46 Million
-100,207 Reduced 68.48%
46,134 $4.36 Million
Q3 2020

Nov 12, 2020

BUY
$82.14 - $91.0 $96,925 - $107,380
1,180 Added 0.81%
146,341 $12.7 Million
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $444,710 - $500,594
5,495 Added 3.93%
145,161 $12.7 Million
Q1 2020

May 06, 2020

BUY
$70.67 - $99.01 $173,848 - $243,564
2,460 Added 1.79%
139,666 $11.5 Million
Q4 2019

Feb 07, 2020

BUY
$84.35 - $95.37 $436,764 - $493,825
5,178 Added 3.92%
137,206 $13 Million
Q3 2019

Nov 08, 2019

BUY
$85.54 - $94.26 $152,261 - $167,782
1,780 Added 1.37%
132,028 $11.5 Million
Q2 2019

Aug 08, 2019

BUY
$75.4 - $92.8 $642,408 - $790,656
8,520 Added 7.0%
130,248 $11.9 Million
Q1 2019

May 07, 2019

BUY
$75.32 - $86.15 $128,495 - $146,971
1,706 Added 1.42%
121,728 $11.7 Million
Q4 2018

Feb 07, 2019

BUY
$73.66 - $82.02 $325,871 - $362,856
4,424 Added 3.83%
120,022 $10.3 Million
Q3 2018

Nov 02, 2018

BUY
$66.94 - $77.43 $7.74 Million - $8.95 Million
115,598 New
115,598 $9.96 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.